Paul Wang to Nanomedicine
This is a "connection" page, showing publications Paul Wang has written about Nanomedicine.
Connection Strength
0.568
-
Wang PC, Blumenthal RP, Zhao Y, Schneider JA, Miller N, Grodzinski P, Gottesman MM, Tinkle S, Wang K, Wang C, Liang XJ. Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S. Cancer Res. 2009 Jul 01; 69(13):5294-5.
Score: 0.350
-
Meng J, Xing J, Wang Y, Lu J, Zhao Y, Gao X, Wang PC, Jia L, Liang X. Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis. Nanoscale. 2011 Nov; 3(11):4713-9.
Score: 0.102
-
Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine. 2016 Feb; 12(2):269-86.
Score: 0.034
-
Lin PC, Lin S, Wang PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv. 2014 Jul-Aug; 32(4):711-26.
Score: 0.030
-
Kumar A, Chen F, Mozhi A, Zhang X, Zhao Y, Xue X, Hao Y, Zhang X, Wang PC, Liang XJ. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale. 2013 Sep 21; 5(18):8307-8325.
Score: 0.029
-
Liang XJ, Meng H, Wang Y, He H, Meng J, Lu J, Wang PC, Zhao Y, Gao X, Sun B, Chen C, Xing G, Shen D, Gottesman MM, Wu Y, Yin JJ, Jia L. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7449-54.
Score: 0.023